Evidence map›Paper›PMID 34413171›Full record

ArticleScience (New York, N.Y.)2021

MIC-Drop: A platform for large-scale in vivo CRISPR screens.

Saba Parvez, Chelsea Herdman, Manu Beerens, Korak Chakraborti, Zachary P Harmer, Jing-Ruey J Yeh, Calum A MacRae, H Joseph Yost, Randall T Peterson

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Review
  2. The endothelial scavenger receptorbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Versatile CRISPR-Cas Tools for Gene Regulation in Zebrafish via an Enhanced Q Binary System.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Signal control during tissue regeneration in adult animals.Nature reviews. Molecular cell biology · 2026
    Review
  7. Article
  8. Article
  9. Zebrafish as a Model System for Polycystic Kidney Disease: Lessons from ift140 Mutants.Journal of the American Society of Nephrology : JASN · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Article
  16. CRISPR-based functional genomics tools in vertebrate models.Experimental & molecular medicine · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Saba ParvezDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-8608-1494
Chelsea HerdmanDepartment of Neurobiology and Molecular Medicine Program, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0002-9531-3725
Manu BeerensDepartment of Cardiovascular Medicine, Genetics and Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7398-7761
Korak ChakrabortiDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-6722-9913
Zachary P HarmerDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0003-3710-9336
Jing-Ruey J YehCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7768-4901
Calum A MacRaeDepartment of Cardiovascular Medicine, Genetics and Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-5181-2664
H Joseph YostDepartment of Neurobiology and Molecular Medicine Program, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0003-2961-5669
Randall T PetersonDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0003-0727-3469

Funding

Training & Education CoreU54NS112107 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI MACRAE, CALUM A. · 2019 to 2023
$16.0M
Genome-wide Analysis of Cardiac Development in ZebrafishU01HL098160 · NHLBI · UNIVERSITY OF UTAH · PI YOST, H. JOSEPH · 2009 to 2014
$8.0M
A Community Zebrafish Resource for Modeling GWAS BiologyR24OD017870 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM, MACRAE, CALUM A. · 2014 to 2021
$6.3M
ADVANCING GENE-EDITING NUCLEASES FOR DIVERSE ZEBRAFISH APPLICATIONSR01GM134069 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RANDALL T PETERSON · 2019 to 2026
$3.7M
Genome-Wide Analysis of Cardiac Development in ZebrafishUM1HL098160 · NHLBI · UNIVERSITY OF UTAH · PI YOST, H. JOSEPH · 2015 to 2019
$3.7M
NHLBI NIH HHS U01 HL098160NHLBI NIH HHS UM1 HL098160NIGMS NIH HHS R01 GM134069NIH HHS R24 OD017870NINDS NIH HHS U54 NS112107
6 · The paper itself

Abstract

CRISPR-Cas9 can be scaled up for large-scale screens in cultured cells, but CRISPR screens in animals have been challenging because generating, validating, and keeping track of large numbers of mutant animals is prohibitive. Here, we introduce Multiplexed Intermixed CRISPR Droplets (MIC-Drop), a platform combining droplet microfluidics, single-needle en masse CRISPR ribonucleoprotein injections, and DNA barcoding to enable large-scale functional genetic screens in zebrafish. The platform can efficiently identify genes responsible for morphological or behavioral phenotypes. In one application, we showed that MIC-Drop could identify small-molecule targets. Furthermore, in a MIC-Drop screen of 188 poorly characterized genes, we discovered several genes important for cardiac development and function. With the potential to scale to thousands of genes, MIC-Drop enables genome-scale reverse genetic screens in model organisms.

Indexed as

CRISPR-Cas SystemsGenetic TestingMicrofluidic Analytical TechniquesAnimalsCardiovascular SystemCell Culture TechniquesHigh-Throughput Nucleotide SequencingZebrafish

Identifiers

PMID34413171
PMCPMC9083377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.